Should You Invest in Ulips now?





Recently launched Ulips have very low charges. Find out why you should buy these insurance-cum-investment plans now

They were once the most bought financial product. Then Ulips became the most reviled investment, forcing a string of reformatory measures. Now these investment-cum-insurance plans have changed once again to become a low-cost investment option. In fact, some of the Ulips introduced in recent months are cheaper than the direct plans of mutual funds.

We won't be surprised if this evokes an angry response from readers. Ulip became a four-letter word due to the high charges levied by insurance companies and rampant mis-selling by distributors. In some cases, the charges were as high as 80% of the first year's premium. Distributors lured gullible investors by not revealing the high charges and showcasing only the returns offered by the market-linked product.

The Insurance Regulatory and Development Authority (Irda) clamped down in 2010, capping the annualised charges of Ulips at 2.25% for the first 10 years of holding. The charges were fixed at this rate because it was the average cost charged by competing products such as mutual funds. With no incentive left for distributors, Ulip sales plunged.

In recent months, insurance companies have sweetened the deal for investors by reducing the charges even further. The Bajaj Allianz Future Gain plan does not levy premium allocation charges if the annual investment is `2 lakh and above. The Edelweiss Tokio Wealth Accumulation Plan doesn't have policy administration charges. Some Ulips, such as Aviva i-Growth and ICICI Prudential Elite Life II, don't have lower charges but compensate long-term investors with `loyalty additions'.

But the Click2Invest plan from HDFC Life is a game changer. The only charge it levies is an annual fund management fee of 1.35% of the corpus value. There is also a mortality charge but that is for the life cover offered to the policyholder. The low charges make the Click2invest plan cheaper than even the direct plan of a diversified equity fund. For instance, the direct plan of the largest equity scheme, HDFC Equity Fund, charges an expense ratio of 1.5% per year.

Some readers may pooh-pooh the idea of saving a sliver on costs. After all, a 0.15% saving on costs makes a difference of only `150 on an investment of `1 lakh. While this may seem small, the difference in the cost can balloon into substantial savings in the long term.

This transformation of Ulips from a costly bundled product to a low-cost option has led to a change of heart among financial planners as well. For long, they have advised clients to keep insurance and investment separate. Low-cost products like this will be suitable for investors who want to combine insurance with investments.

He's not alone. With more low-cost Ulips on the anvil (at least two companies are awaiting Irda's approval for their low-cost Ulips), many financial planners are changing their tune. The Click2Invest plan from HDFC Life is a good product. We are recommending it to our clients. This Ulip will give the mutual fund industry a run for its money.

Indeed, it is time to get rid of the historical aversion to Ulips and look at them through the prism of lower charges. This will not be easy because a lot of investors have been scarred by their experience with Ulips. Many have lost money due to the doublespeak of distributors and the failure (or unwillingness) of insurance companies to redress their grievances. Policyholders lost money even though the markets were shooting up. Buyers didn't realise that even though their funds went up by 15-20% in a year, they were suffering losses because only 40-50% of their money was actually invested in the first 2-3 years. "The new Ulips are facing the baggage of old Ulips.